| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.12 | 4e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-05 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |